Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 313

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 4
Chunk 313
---
10.1
     
    Form of Securities Purchase Agreement (incorporated
    by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    10.2
     
    Form of Securities Purchase Agreement (incorporated
    by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on February 6, 2025)
  
    31.1*
     
    Rule 13a-14(a)/15d-14(a) Certification of the President and Chief Executive Officer of 60 Degrees Pharmaceuticals, Inc.
  
    31.2*
     
    Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer of 60 Degrees Pharmaceuticals, Inc.
  
    32.1**
     
    Section 1350 Certification of the President and Chief Executive Officer of 60 Degrees Pharmaceuticals, Inc.
  
    32.2**
     
    Section 1350 Certification of the Chief Financial Officer of 60 Degrees Pharmaceuticals, Inc.
  
    101.INS*
     
    Inline XBRL Instance Document
  
    101.SCH*
     
    Inline XBRL Taxonomy Extension Schema Document
  
    101.CAL*
     
    Inline XBRL Taxonomy Extension Calculation Linkbase
    Document
  
    101.DEF*
     
    Inline XBRL Taxonomy Extension Definition Linkbase
    Document
  
    101.LAB*
     
    Inline XBRL Taxonomy Extension Label Linkbase Document
  
    101.PRE*
     
    Inline XBRL Taxonomy Extension Presentation Linkbase
    Document
  
    104*
     
    Cover Page Interactive Data File (embedded within
    the Inline XBRL document)

    *
    Filed herewith.

    **
    Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

39

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on